List of Tables
Table 1. Global GABA Receptor Agonist Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GABA Receptor Agonist Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global GABA Receptor Agonist Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global GABA Receptor Agonist Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global GABA Receptor Agonist Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market GABA Receptor Agonist Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of GABA Receptor Agonist Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GABA Receptor Agonist Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GABA Receptor Agonist Drug, Product Type & Application
Table 12. Global Key Manufacturers of GABA Receptor Agonist Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GABA Receptor Agonist Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GABA Receptor Agonist Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global GABA Receptor Agonist Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global GABA Receptor Agonist Drug Sales Market Share by Region (2020-2025)
Table 19. Global GABA Receptor Agonist Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global GABA Receptor Agonist Drug Sales Market Share by Region (2026-2031)
Table 21. Global GABA Receptor Agonist Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2020-2025)
Table 23. Global GABA Receptor Agonist Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2026-2031)
Table 25. North America GABA Receptor Agonist Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America GABA Receptor Agonist Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America GABA Receptor Agonist Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America GABA Receptor Agonist Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America GABA Receptor Agonist Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe GABA Receptor Agonist Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe GABA Receptor Agonist Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe GABA Receptor Agonist Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe GABA Receptor Agonist Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe GABA Receptor Agonist Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific GABA Receptor Agonist Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific GABA Receptor Agonist Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific GABA Receptor Agonist Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America GABA Receptor Agonist Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America GABA Receptor Agonist Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America GABA Receptor Agonist Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America GABA Receptor Agonist Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America GABA Receptor Agonist Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global GABA Receptor Agonist Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global GABA Receptor Agonist Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global GABA Receptor Agonist Drug Sales Market Share by Type (2020-2025)
Table 53. Global GABA Receptor Agonist Drug Sales Market Share by Type (2026-2031)
Table 54. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2020-2025)
Table 57. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2026-2031)
Table 58. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global GABA Receptor Agonist Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global GABA Receptor Agonist Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global GABA Receptor Agonist Drug Sales Market Share by Application (2020-2025)
Table 63. Global GABA Receptor Agonist Drug Sales Market Share by Application (2026-2031)
Table 64. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2020-2025)
Table 67. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2026-2031)
Table 68. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Advicenne Company Information
Table 71. Advicenne Description and Business Overview
Table 72. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Advicenne GABA Receptor Agonist Drug Product
Table 74. Advicenne Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AstraZeneca GABA Receptor Agonist Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Athena Drug Delivery Solutions Company Information
Table 81. Athena Drug Delivery Solutions Description and Business Overview
Table 82. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product
Table 84. Athena Drug Delivery Solutions Recent Developments/Updates
Table 85. Biocodex Company Information
Table 86. Biocodex Description and Business Overview
Table 87. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Biocodex GABA Receptor Agonist Drug Product
Table 89. Biocodex Recent Developments/Updates
Table 90. Elan Corporation Company Information
Table 91. Elan Corporation Description and Business Overview
Table 92. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Elan Corporation GABA Receptor Agonist Drug Product
Table 94. Elan Corporation Recent Developments/Updates
Table 95. Eli Lilly and Company Company Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Eli Lilly and Company GABA Receptor Agonist Drug Product
Table 99. Eli Lilly and Company Recent Developments/Updates
Table 100. H.LundBeck, Merck and Co Company Information
Table 101. H.LundBeck, Merck and Co Description and Business Overview
Table 102. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product
Table 104. H.LundBeck, Merck and Co Recent Developments/Updates
Table 105. GlaxoSmithKline Company Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline GABA Receptor Agonist Drug Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. NovaDel Pharma Company Information
Table 111. NovaDel Pharma Description and Business Overview
Table 112. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. NovaDel Pharma GABA Receptor Agonist Drug Product
Table 114. NovaDel Pharma Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Novartis GABA Receptor Agonist Drug Product
Table 119. Novartis Recent Developments/Updates
Table 120. OVATION Pharmaceuticals Company Information
Table 121. OVATION Pharmaceuticals Description and Business Overview
Table 122. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product
Table 124. OVATION Pharmaceuticals Recent Developments/Updates
Table 125. Osmotica Pharmaceutical Company Information
Table 126. Osmotica Pharmaceutical Description and Business Overview
Table 127. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product
Table 129. Osmotica Pharmaceutical Recent Developments/Updates
Table 130. Pfizer Company Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Pfizer GABA Receptor Agonist Drug Product
Table 134. Pfizer Recent Developments/Updates
Table 135. sanofi-aventis Company Information
Table 136. sanofi-aventis Description and Business Overview
Table 137. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. sanofi-aventis GABA Receptor Agonist Drug Product
Table 139. sanofi-aventis Recent Developments/Updates
Table 140. VIVUS Company Information
Table 141. VIVUS Description and Business Overview
Table 142. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. VIVUS GABA Receptor Agonist Drug Product
Table 144. VIVUS Recent Developments/Updates
Table 145. XenoPort Company Information
Table 146. XenoPort Description and Business Overview
Table 147. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. XenoPort GABA Receptor Agonist Drug Product
Table 149. XenoPort Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. GABA Receptor Agonist Drug Distributors List
Table 153. GABA Receptor Agonist Drug Customers List
Table 154. GABA Receptor Agonist Drug Market Trends
Table 155. GABA Receptor Agonist Drug Market Drivers
Table 156. GABA Receptor Agonist Drug Market Challenges
Table 157. GABA Receptor Agonist Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of GABA Receptor Agonist Drug
Figure 2. Global GABA Receptor Agonist Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GABA Receptor Agonist Drug Market Share by Type: 2024 & 2031
Figure 4. Bamaluzole Product Picture
Figure 5. Phenibut Product Picture
Figure 6. Baclofen Product Picture
Figure 7. Gaboxadol Product Picture
Figure 8. Klonopin (clonazepam) Product Picture
Figure 9. Tiagbine Product Picture
Figure 10. Global GABA Receptor Agonist Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global GABA Receptor Agonist Drug Market Share by Application: 2024 & 2031
Figure 12. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 13. Psychiatric Disorders and Depression
Figure 14. Alzheimer
Figure 15. Epilepsy and Seizure
Figure 16. Anxiety and Sleep Disorders
Figure 17. Obesity and Alcoholism
Figure 18. Global GABA Receptor Agonist Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global GABA Receptor Agonist Drug Market Size (2020-2031) & (US$ Million)
Figure 20. Global GABA Receptor Agonist Drug Sales (2020-2031) & (K Pcs)
Figure 21. Global GABA Receptor Agonist Drug Average Price (USD/Pcs) & (2020-2031)
Figure 22. GABA Receptor Agonist Drug Report Years Considered
Figure 23. GABA Receptor Agonist Drug Sales Share by Manufacturers in 2024
Figure 24. Global GABA Receptor Agonist Drug Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest GABA Receptor Agonist Drug Players: Market Share by Revenue in GABA Receptor Agonist Drug in 2024
Figure 26. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global GABA Receptor Agonist Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America GABA Receptor Agonist Drug Sales Market Share by Country (2020-2031)
Figure 29. North America GABA Receptor Agonist Drug Revenue Market Share by Country (2020-2031)
Figure 30. U.S. GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2020-2031)
Figure 33. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2020-2031)
Figure 34. Germany GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region (2020-2031)
Figure 41. China GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Taiwan GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Indonesia GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Thailand GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Malaysia GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Philippines GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Latin America GABA Receptor Agonist Drug Sales Market Share by Country (2020-2031)
Figure 52. Latin America GABA Receptor Agonist Drug Revenue Market Share by Country (2020-2031)
Figure 53. Mexico GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Brazil GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Argentina GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2020-2031)
Figure 58. Turkey GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. UAE GABA Receptor Agonist Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Sales Market Share of GABA Receptor Agonist Drug by Type (2020-2031)
Figure 62. Global Revenue Market Share of GABA Receptor Agonist Drug by Type (2020-2031)
Figure 63. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Type (2020-2031)
Figure 64. Global Sales Market Share of GABA Receptor Agonist Drug by Application (2020-2031)
Figure 65. Global Revenue Market Share of GABA Receptor Agonist Drug by Application (2020-2031)
Figure 66. Global GABA Receptor Agonist Drug Price (USD/Pcs) by Application (2020-2031)
Figure 67. GABA Receptor Agonist Drug Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
